Potential utility of p63 expression in differential diagnosis of non-small-cell lung carcinoma and its effect on prognosis of the disease
MEDICAL SCIENCE MONITOR, cilt.20, ss.219-226, 2014 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 20
- Basım Tarihi: 2014
- Doi Numarası: 10.12659/msm.890394
- Dergi Adı: MEDICAL SCIENCE MONITOR
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.219-226
- Anahtar Kelimeler: Carcinoma, Non-Small-Cell Lung - pathology, Diagnosis, Differential, Reverse Transcriptase Polymerase Chain Reaction - methods, IMMUNOHISTOCHEMICAL MARKERS, P53 HOMOLOG, CANCER, CLASSIFICATION, ADENOCARCINOMA, EPITHELIUM, SURVIVAL, P73
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Akdeniz Üniversitesi Adresli: Evet
Özet
Background: P63 is a gene located in chromosome 3q27-29, which has been implicated in regulation of stem cell commitment and promotion of squamous differentiation in various tissues. The aim of this study was to investigate whether there was a correlation between p63 expression, differential diagnosis of lung carcinoma, and prognosis.